Internal Medicine · San Francisco, CA
NPI
1447303565
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2100 Webster St, Suite 516
San Francisco, CA, 94115
Phone (912) 345-0940
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$773K
2,226 prescriptions
Company payments, 2025
$377
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Bryan Ristow prescribed most often to Medicare patients was Metoprolol Succinate, with 183 prescriptions and refills. In total Bryan Ristow wrote 2,226 Medicare prescriptions that cost $773K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metoprolol Succinate Generic | 183 | 479 | 62 | $2,364 |
| Eliquis Apixaban | 162 | 325 | 48 | $196K |
| Jardiance Empagliflozin | 144 | 296 | 37 | $144K |
| Atorvastatin Calcium Generic | 135 | 389 | 47 | $747 |
| Spironolactone Generic | 131 | 349 | 41 | $1,000 |
| Furosemide Generic | 117 | 299 | 41 | $582 |
| Losartan Potassium Generic | 98 | 253 | 30 | $575 |
| Entresto Sacubitril/Valsartan | 94 | 157 | 27 | $97K |
| Carvedilol Generic | 94 | 259 | 32 | $791 |
| Clopidogrel Clopidogrel Bisulfate | 86 | 230 | 27 | $1,151 |
| Torsemide Generic | 49 | 117 | 13 | $462 |
| Xarelto Rivaroxaban | 48 | 90 | 12 | $50K |
| Lisinopril Generic | 46 | 130 | 15 | $263 |
| Bumetanide Generic | 45 | 119 | 16 | $2,659 |
| Amlodipine Besylate Generic | 37 | 108 | 16 | $192 |
Brand drugs: 596 claims; generic drugs: 1,630 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryan Ristow $377 ($377 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbott Laboratories with $186.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.